Sogroya

Generic name: Somapacitan-beco
Dosage form: injection, for subcutaneous use
Drug class: Growth hormones

Usage of Sogroya

Sogroya is a prescription medicine that is used to treat people with growth hormone deficiency.

Sogroya is given by injection under the skin (suBCutaneous) to replace growth hormones that are normally produced in the body.

Sogroya side effects

Sogroya may cause serious side effects, including:

  • high risk of death in people who have critical illnesses because of heart or stomach surgery, trauma or serious breathing (respiratory) problems.
  • increased risk of growth of cancer or a tumor that is already present and increased risk of the return of cancer or a tumor in people who were treated with radiation to the brain or head as children and who developed low growth hormone problems. Your or your child’s healthcare provider will need to monitor you or your child for a return of cancer or a tumor. Contact the healthcare provider if you or your child start to have sudden changes in behavior, headaches, vision problems, or changes in moles, birthmarks, or the color of your or your child’s skin.
  • new or worsening high blood sugar (hyperglycemia) or diabetes. You or your child’s blood sugar may need to be monitored during treatment.
  • increase in pressure in the skull (intracranial hypertension). If you or your child have headaches, eye problems, nausea or vomiting, contact the healthcare provider.
  • serious allergic reactions. Get medical help right away if you or your child have the following symptoms:
  • swelling of the face, lips, mouth, or tongue
  • trouble breathing
  • wheezing
  • severe itching
  • skin rashes, redness, or swelling
  • dizziness or fainting
  • fast heartbeat or pounding in your chest
  • sweating
  • your or your child’s body holding too much fluid (fluid retention) such as swelling in the hands and feet, pain in your or your child’s joints or muscles or nerve problems that cause pain, burning or tingling in the hands, arms, legs and feet. Tell your or your child’s healthcare provider if you or your child have any of these signs or symptoms of fluid retention.
  • decrease in a hormone called cortisol. The healthcare provider will do blood tests to check your or your child’s cortisol levels. Tell your or your child’s healthcare provider if you or your child has darkening of the skin, severe fatigue, dizziness, weakness, or weight loss.
  • decrease in thyroid hormone levels. Decreased thyroid hormone levels may affect how well Sogroya works. The healthcare provider will do blood tests to check your or your child’s thyroid hormone levels.
  • severe and constant abdominal pain. This could be a sign of pancreatitis. Tell your or your child’s healthcare provider if you or your child has any new abdominal pain.
  • loss of fat and tissue weakness in the area of skin you or your child inject. Talk to your or your child’s healthcare provider about rotating the areas where you or your child inject Sogroya.
  • worsening of curvature of the spine in children (scoliosis).
  • hip and knee pain or a limp in children (slipped capital femoral epiphysis).
  • high risk of sudden death in children with Prader-Willi syndrome who are severely obese or have breathing problems, including sleep apnea.
  • increase in phosphorus, alkaline phosphatase and parathyroid hormone levels in your blood. Your healthcare provider will do blood tests to check this.
  • increase in phosphorus, alkaline phosphatase, and parathyroid hormone levels in your blood. Your or your child’s healthcare provider will do blood tests to check this.

    • The most common side effects in adults include:

  • back pain
  • joint pain
  • indigestion
  • sleep problems
  • dizziness
  • swelling of the tonsils (tonsillitis)
  • vomiting
  • high blood pressure
  • increase in the level of an enzyme in your blood called creatine phosphokinase
  • weight gain
  • low red blood cells (anemia)

    • The most common side effects in children include:

  • common cold
  • headache
  • fever
  • pain in extremity
  • reaction to injection

    • These are not all the possible side effects.Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

    You may also report side effects to Novo Nordisk at 1-888-668-6444.

    Before taking Sogroya

    You should not use Sogroya if:

  • you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing (respiratory) problems.
  • you have cancer or other tumors.
  • you are allergic to somapacitan-beco or any of the ingredients. See the end of this page for a complete list of ingredients.
  • your healthcare provider tells you that you have certain types of eye problems caused by diabetes (diabetic retinopathy).
  • you are a child with closed bone growth plates.
  • you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea (briefly stop breathing during sleep).

    • Relate drugs

    How to use Sogroya

  • Your healthcare provider will show you how to inject Sogroya.
  • Use exactly as your healthcare provider tells you to.
  • Use Sogroya one time each week.
  • If you miss a dose, take the missed dose as soon as possible within 3 days (72 hours) after the missed dose. If more than 3 days (72 hours) have passed, skip the missed dose and take your next dose on the regularly scheduled day.
  • Sogroya pens are for use by one person only.
  • Do not share your pens and needles with another person, even if the needle has been changed. You may give another person an infection or get an infection from them.
  • See Instructions for Use below.

    • What other drugs will affect Sogroya

    Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Sogroya may affect how other medicines work, and other medicines may affect how Sogroya works.

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords